Testing 1,2,3: Best Practices for Genetic Test Utilization Management as Part of a Precision Medicine Strategy

October 2nd, 2018 1:00PM ET

The pace of genomic and genetic medical innovation is breathtaking, and greatly affects the application of precision medicine for health plan members. Plans not only have to address policy for the sheer number of genetic tests on the market – more than 70,000 – but also how to ensure that members undergo only medically appropriate testing, and that both members and ordering providers make fully informed testing decisions. 

It’s clear there’s a need for payers to provide high-touch genetic testing support to physicians and members so that the right test is ordered for the right member at the right time. 

At InformedDNA, our work with health plans across the country points to a number of best practices for genetic test utilization management (UM) that help to ensure that members receive only appropriate, evidence-based genetic testing, while also promoting the use of genetic tests to inform appropriate utilization of other expensive therapies.

Register Here: 
John Gaines
Vice President, Client Development

John has more than 30 years of diverse experience across health plans, health systems, physician organizations and healthcare IT vendors. John leads a number of growth initiatives for InformedDNA, including management of key client relationships. Prior to InformedDNA, he helped lead the growth of McKesson Corporation’s genetic test-related products. John has also held leadership positions with PricewaterhouseCoopers, Montefiore Medical Center and Siebel Systems.

We respect your privacy. By submitting your registration information to HealthPayerIntelligence.com you agree to receive email communications from Xtelligent Media. Please read our Privacy Policy which contains important disclosures about how we collect and use your registration and other information. You can view our Terms of Service or you may contact us at: contactus@xtelligentmedia.com
Sponsored by: InformedDNA

InformedDNA is the authority on the appropriate use of genetic testing. Leveraging expertise of the largest full-time staff of board-certified genetics specialists, InformedDNA helps ensure that health plans, hospitals, providers and patients all have access to the highest quality genetics services. Key offerings include genetic counseling, genetic testing utilization management, and clinical trial support. www.InformedDNA.com

Megan Czarniecki, MS, CGC
Vice President, Genetic Analyst Services

Megan oversees InformedDNA's genetic testing utilization management program, policy, and consulting work. Megan holds dual Masters’ degrees in Genetic Counseling and Medical Humanities & Bioethics from Northwestern University. Prior to joining InformedDNA, Megan practiced as a clinical genetic counselor specializing in reproductive genetics and medical ethics.